date:Apr 24, 2013
mited and those that are on the market do not work for every sufferer.
Migraines are an extremely common disorder, and it affects people really in the prime of their lives, Rob Lenz, who is leading Amgens migraine drug development, said in an interview. Still, no drugs have been developed specifically for the treatment of migraines, he said. They were developed as anti-epileptics, or blood pressure lowering agents.
That may soon change. Amgen, based in Thousand Oaks, California, and other bio